Media coverage about WellCare Health Plans (NYSE:WCG) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. WellCare Health Plans earned a coverage optimism score of 0.20 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.9356023069731 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Here are some of the news articles that may have impacted Accern’s analysis:

Shares of WellCare Health Plans (NYSE WCG) traded up $0.44 during midday trading on Friday, reaching $193.95. The company’s stock had a trading volume of 192,888 shares, compared to its average volume of 346,323. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.49. The company has a market cap of $8,630.00, a price-to-earnings ratio of 27.43, a P/E/G ratio of 1.24 and a beta of 0.88. WellCare Health Plans has a 52-week low of $136.23 and a 52-week high of $221.75.

WellCare Health Plans (NYSE:WCG) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.11. The firm had revenue of $4.35 billion during the quarter, compared to analyst estimates of $4.32 billion. WellCare Health Plans had a return on equity of 17.10% and a net margin of 2.20%. The firm’s quarterly revenue was up 23.5% on a year-over-year basis. During the same period last year, the company posted $1.03 EPS. analysts predict that WellCare Health Plans will post 9.79 EPS for the current year.

Several analysts recently commented on the company. Zacks Investment Research upgraded WellCare Health Plans from a “hold” rating to a “buy” rating and set a $216.00 target price on the stock in a research report on Tuesday, February 20th. Cantor Fitzgerald restated a “buy” rating and issued a $235.00 target price on shares of WellCare Health Plans in a research report on Tuesday, February 6th. Deutsche Bank raised their target price on WellCare Health Plans to $240.00 and gave the company a “buy” rating in a research report on Monday, November 20th. Morgan Stanley raised their target price on WellCare Health Plans from $214.00 to $220.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 7th. Finally, Bank of America increased their price target on WellCare Health Plans from $210.00 to $215.00 and gave the company a “neutral” rating in a research note on Friday, November 17th. Seven analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $217.86.

ILLEGAL ACTIVITY NOTICE: “Somewhat Favorable Media Coverage Somewhat Unlikely to Impact WellCare Health Plans (WCG) Stock Price” was originally published by Watch List News and is owned by of Watch List News. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at

WellCare Health Plans Company Profile

WellCare Health Plans, Inc is a managed care company. The Company focuses on government-sponsored managed care services, primarily through Medicaid, Medicare Advantage (MA) and Medicare Prescription Drug Plans (PDPs), to families, children, seniors and individuals with medical needs. The Company operates through three segments: Medicaid Health Plans, Medicare Health Plans and Medicare PDPs.

Insider Buying and Selling by Quarter for WellCare Health Plans (NYSE:WCG)

Receive News & Ratings for WellCare Health Plans Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WellCare Health Plans and related companies with's FREE daily email newsletter.